Trending Topic

Akebia Therapeutics

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

Akebia Therapeutics Secures Extended Patent Protection for Vafseo® Through 2043
TrademarksUSA

Akebia Therapeutics Secures Extended Patent Protection for Vafseo® Through 2043

Akebia Therapeutics has been granted a U.S. patent extending intellectual property protection for its anemia treatment Vafseo® (vadadustat) until January 18, 2043. The patent, covering methods addressing drug-drug interactions, is eligible for Orange Book listing, reinforcing Vafseo’s market exclusivity. Approved by t…

Tuesday, November 17, 2026
Newsletters & Digests

Follow Akebia Therapeutics

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.